Related Experiment Video
Updated: Mar 10, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.7K
Preserving Cognitive Function in Patients with Atrial Fibrillation
Tina Lin1, Erik Wissner1, Roland Tilz1
1Asklepios-Klinik St. Georg, Dept. Of Cardiology, Lohmühlenstr. 5, 20099 Hamburg/Germany.
Journal of Atrial Fibrillation
|December 14, 2016
Summary
Atrial fibrillation (AF), a common heart rhythm disorder, is linked to cognitive decline. This review explores treatments to reduce stroke risk and preserve brain function in AF patients.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Atrial fibrillation (AF) is the most common cardiac arrhythmia, increasing with age and leading to thromboembolism, including stroke.
- Cognitive dysfunction prevalence also rises with age, with a known correlation to AF, though causality is unproven.
- Optimizing AF management is crucial for preserving cognitive function, especially as AF prevalence grows.
Approach:
- This review synthesizes current evidence on the AF-cognitive dysfunction association.
- It examines established and novel medical treatments for AF, focusing on anticoagulation strategies.
- Procedural interventions like catheter ablation and their impact on thromboembolic risk are discussed.
Key Points:
- Novel anticoagulants and evolving catheter ablation techniques offer new AF management options.
- These treatments aim to mitigate thromboembolic risks, potentially preserving cognitive function.
- The interplay between AF, cognitive impairment, and healthcare burden necessitates optimized treatment strategies.
Conclusions:
- Further research is needed to establish a direct causal link between AF and cognitive dysfunction.
- Effective management of AF, including anticoagulation and procedural interventions, is vital for reducing stroke risk.
- Preserving cognitive function in aging populations with AF requires a comprehensive approach to treatment and care.
Keywords:
Anti-CoagulationAtrial FibrillationCatheter AblationCognitive DysfunctionThromboembolism and StrokeMore Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.3K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
2.2K
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
554
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
554
01:26Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
01:23Atherosclerosis IV: Nursing Management
539
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
539
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:28Acute Coronary Syndrome IV: Interprofessional Care
374
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
01:26Coronary Artery Disease IV: Preventive Measures
790
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
790